+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Application of strengths, weaknesses, opportunities and threats analysis in the development of a health technology assessment program

, : Application of strengths, weaknesses, opportunities and threats analysis in the development of a health technology assessment program. Health Policy 58(1): 27-35

There has been recent interest in developing a health technology assessment (HTA) function in Estonia. A group of individuals knowledgeable about HTA in Canada, Germany, Romania and Spain, along with representatives of the University of Tartu, Estonia, was convened by the Institute of Health Economics in Edmonton, Canada, to consider options for such a function. In a one-day workshop strengths, weaknesses, opportunities and threats (SWOT) analyses of HTA were conducted, first at a 'global' level, and then of the Estonian situation. The 'global' SWOT analysis yielded a large number of items that pertain to institutionalized HTA in a generic sense, i.e. not based on any individual HTA agency. The 'Estonian' SWOT yielded a subset of items, which pertain to development of HTA in that country. Ten actionable steps were then developed on the basis of this subset, which could be used to initiate the creation of an HTA body in Estonia.


PMID: 11518600

Other references

Lee, S.Y., 1962: Study on the physical development of children in the area of islands. Chosen I-Bo. Korean Medical Journal 7: 789-798

E.H.ndawy, H.H.; Zeid, I.M.; Mohamed, Z.K., 1998: The biological control of soft rot disease in melon caused by Erwinia carotovora subsp. carotovora using Pseudomonas fluorescens. The effect of Pseudomonas fluorescens on soft-rot formation in melon (Musk or Netted varietal group) seedlings infected with a virulent strain of E. carotovora subsp. carotovora was evaluated. Pseudomonas fluorescens strain 346683 exhibited in vit...

Bradley, M., 1973: Business aspects of horse production. 1. capital and credit--why bankers traditional fear of horses; what to do about it. Stud managers' handbook: 194

Mizote, H.; Gu, L.; Sugiyama, M.; Kakegawa, T., 1988: Congenital segmental dilatation of the jejunum with malrotation. Kurume Medical Journal 35(3): 135-138

Caputo, V.; D.N.rdo, D.; Antolini, M.; Pitucco, G.; Gallo, P.; Scibilia, G.; Macchiarelli, A.G.; Cassisi, A.; Caretta, Q.; Bianco, G., 1989: Myocardial necrosis imaging by 111In monoclonal antimyosin Fab. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology 16(6): 641-643

Dahlin, C., 2006: It takes my breath away end-stage COPD. Part 2: pharmacologic and nonpharmacologic management of dyspnea and other symptoms. Home Healthcare Nurse 24(4): 218-24; Quiz 225-6

Vallabhajosula, S.; Nikolopoulou, A.; Babich, J.W.; Osborne, J.R.; Tagawa, S.T.; Lipai, I.; Solnes, L.; Maresca, K.P.; Armor, T.; Joyal, J.L.; Crummet, R.; Stubbs, J.B.; Goldsmith, S.J., 2015: 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer. Prostate-specific membrane antigen (PSMA) is a well-established target for developing radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently reported that novel (99m)Tc-labeled small-molecule PSMA inhibitors bind w...

Viva, E.; Ferrari-Parabita, G., 1979: Anatomo-pathological and ultrastructural changes in parotid glands in the course of Sjögren's syndrome. Polski Tygodnik Lekarski 34(38): 1503-1504

Reuter F., 1976: Land subsidence and landslides in salt karst areas of East Germany. Congres International de Speleologie, Actes--International Congress of Speleology, Proceedings

Godler, D.E.; Slater, H.R.; Bui, Q.M.; Storey, E.; Ono, M.Y.; Gehling, F.; Inaba, Y.; Francis, D.; Hopper, J.L.; Kinsella, G.; Amor, D.J.; Hagerman, R.J.; Loesch, D.Z., 2012: Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. Cognitive status in females with mutations in the FMR1 (fragile X mental retardation 1) gene is highly variable. A biomarker would be of value for predicting which individuals were liable to develop cognitive impairment and could benefit from earl...